LIC of India:企業の戦略・SWOT・財務分析

◆英語タイトル:LIC of India - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY3633
◆発行会社(調査会社):MarketLine
◆発行日:2019年12月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥19,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥38,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥57,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

LIC of India – Strategy, SWOT and Corporate Finance Report
Summary

LIC of India – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

LIC of India (LIC or ‘the company’) is primarily involved in providing life insurance related services. These comprise of individual assurance, general annuities, pensions, non-linked health, unit linked business, and group insurance businesses. Its product portfolio includes endowment assurance plans, money back plans, term assurance plans, pension plans, special plan, Aam Admi Bima Yojna, unit plans, special plans, health plan and group schemes. LIC operates through its zonal areas located in Mumbai, Delhi, Kolkata, Chennai, Hyderabad, Kanpur, Bhopal, and Patna. The company primarily operates in India. LIC is headquartered in Mumbai, Maharashtra, India.

Scope

- Detailed information on LIC of India required for business and competitor intelligence needs
- A study of the major internal and external factors affecting LIC of India in the form of a SWOT analysis
- An in-depth view of the business model of LIC of India including a breakdown and examination of key business segments
- Intelligence on LIC of India’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about LIC of India, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of LIC of India and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess LIC of India as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on LIC of India’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
LIC of India: Company Overview
LIC of India: Overview and Key Facts
LIC of India: Overview
LIC of India: Key Facts
LIC of India: Key Employees
LIC of India: Key Employee Biographies
LIC of India: Major Products and Services
LIC of India: Company History
LIC of India: Management Statement
LIC of India: Key Competitors
LIC of India: Company Analysis
LIC of India: Business Description
LIC of India: SWOT Analysis
LIC of India: SWOT Overview
LIC of India: Strengths
LIC of India: Weaknesses
LIC of India: Opportunities
LIC of India: Threats
LIC of India: Corporate Financial Deals Activity
LIC of India: Financial Deals Overview
LIC of India: Targets and Partners
LIC of India: Top Deals 2015 – 2019YTD*
LIC of India: Advisors
LIC of India: Top Financial Advisors
LIC of India: Mergers and Acquisitions
LIC of India: Corporate Venturing
LIC of India: Partnership
LIC of India: Divestments
LIC of India: Recent Developments
LIC of India: News and Events Summary
LIC of India: Business Expansion
LIC of India: Contracts
LIC of India: Corporate Governance
LIC of India: Corporate Social Responsibility
LIC of India: Financial Deals
LIC of India: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: LIC of India: Key Facts
Table 2: LIC of India: Key Employees
Table 3: LIC of India: Company History
Table 4: LIC of India: Key Competitors
Table 5: LIC of India: Deal Activity by Deal Type - Volume (TTM*)
Table 6: LIC of India: M&A Activity by Geography (TTM*)
Table 7: LIC of India: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: LIC of India: M&A Average Deal Size - Value (US$m)
Table 9: LIC of India: Targets and Partners
Table 10: LIC of India: Top Deals 2015 - 2019YTD*
Table 11: LIC of India: Financial Advisor Ranking by Value (US$m)
Table 12: LIC of India: M&A Volume and Value Trend (2015 - YTD*2019)
Table 13: LIC of India: M&A Activity by Geography (2015 - YTD*2019)
Table 14: LIC of India: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Table 15: LIC of India: Corporate Venturing by Geography (2015 - YTD*2019)
Table 16: LIC of India: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 17: LIC of India: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 18: LIC of India: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 19: LIC of India: Divestments by Geography (2015 - YTD*2019)
Table 20: LIC of India: News and Events Summary
Table 21: LIC of India: Business Expansion
Table 22: LIC of India: Contracts
Table 23: LIC of India: Corporate Governance
Table 24: LIC of India: Corporate Social Responsibility
Table 25: LIC of India: Financial Deals
Table 26: LIC of India: Strategy and Operations

★海外企業調査レポート[LIC of India:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Motif Bio Plc (MTFB):製薬・医療:M&Aディール及び事業提携情報
    Summary Motif Bio Plc (Motif Bio), formerly Motif Bio Ltd, is a clinical-stage biopharmaceutical company that focuses on the development of novel antibiotics to treat patients with infections caused by multi-drug resistant bacteria. The company develops Iclaprim, a targeted Gram-positive1 antibiotic …
  • Huawei Technologies Co Ltd:電力:M&Aディール及び事業提携情報
    Summary Huawei Technologies Co., Ltd. (Huawei), a subsidiary of Huawei Investment & Holding Co., Ltd, is an information and communication technology company. The company’s product portfolio includes mobile, broadband, core network, transmission network, and data communication products, besides value …
  • AnGes Inc (4563):企業の財務・戦略的SWOT分析
    AnGes Inc (4563) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • SPIE SA (SPIE):電力:M&Aディール及び事業提携情報
    Summary SPIE SA (SPIE) provides multi-technical services in the areas of energy and communications. The company designs, builds, operates and maintains energy efficient and environmental facilities. It provides various products and services for developing efficient buildings. Its service offerings i …
  • Verbund AG:発電所・企業SWOT分析
    Verbund AG - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executi …
  • Essilor International S.A.:企業の戦略・SWOT・財務情報
    Essilor International S.A. - Strategy, SWOT and Corporate Finance Report Summary Essilor International S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Transcontinental Inc. (TCL.A):企業の財務・戦略的SWOT分析
    Transcontinental Inc. (TCL.A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Vertex Pharmaceuticals Inc (VRTX)-製薬・医療分野:企業M&A・提携分析
    Summary Vertex Pharmaceuticals Inc (Vertex) is a biotechnology company that carries out the discovery, development and commercialization of novel drugs for the treatment of serious and life-threatening diseases. The company offers Orkambi (ivacaftor/lumacaftor) and Kalydeco (ivacaftor) for the treat …
  • Arkansas Children’s Hospital:企業の戦略的SWOT分析
    Arkansas Children's Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • United Therapeutics Corp (UTHR)-医療機器分野:企業M&A・提携分析
    Summary United Therapeutics Corp (UTC) develops and commercializes innovative pharmaceutical products for the treatment of cardiovascular disorders, particularly pulmonary arterial hypertension and infectious diseases. The company's products consist of prostacyclin analogues including Remodulin (tre …
  • SoTHERLY Hotels Inc:企業の戦略・SWOT・財務情報
    SoTHERLY Hotels Inc - Strategy, SWOT and Corporate Finance Report Summary SoTHERLY Hotels Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • LIC of India:企業の戦略・SWOT・財務情報
    LIC of India - Strategy, SWOT and Corporate Finance Report Summary LIC of India - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Pristine Sun LLC:電力:M&Aディール及び事業提携情報
    Summary Pristine Sun LLC (Pristine Sun) is a renewable energy company that develops small utility-scale solar PV power plants. The company offers consulting, and project financing and funding services. Its consulting services include solar project development, operation and maintenance, EPC and inst …
  • HitGen LTD:製薬・医療:M&Aディール及び事業提携情報
    Summary HitGen LTD (HitGen) is a drug company that concentrates on hit identification and lead generation in the early phases of drug discoveries and development. The company provides OpenDEL, a collection of DNA encoded library compounds based on distinct, diverse and drug structures. It offers bio …
  • Flight Centre Travel Group Limited (FLT):企業の財務・戦略的SWOT分析
    Flight Centre Travel Group Limited (FLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Ball Aerospace & Technologies Corp.:企業の戦略・SWOT・財務情報
    Ball Aerospace & Technologies Corp. - Strategy, SWOT and Corporate Finance Report Summary Ball Aerospace & Technologies Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Madhya Pradesh Power Generating Company Ltd:発電所・企業SWOT分析
    Madhya Pradesh Power Generating Company Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, info …
  • GE Healthcare LLC-製薬・医療分野:企業M&A・提携分析
    Summary GE Healthcare LLC (GE Healthcare) a business unit of General Electric Company, is a global medical device provider that designs, develops, manufactures, and distributes diagnostic imaging and clinical systems; products and services for drug discovery, biopharmaceutical manufacturing and cell …
  • Pharmaron Beijing Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharmaron Beijing Co Ltd (Pharmaron) is a life science service company that provides drug research and development services in the areas of chemistry, biology, pharmacology, DMPK, toxicology, and chemical development. The company's service offerings include synthetic, medicinal and analytica …
  • Trevena Inc (TRVN):製薬・医療:M&Aディール及び事業提携情報
    Summary Trevena Inc (Trevena) is a biotechnology company that discovers and develops G-protein coupled receptor targeted medicines. The company provides products such as RV027, TRV130, TRV734 and TRV250. Its TRV027 is an intravenous drug used for the treatment of acute heart failure in combination w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆